JOHNSON & JOHNSON Cash & Equivalents 2006-2026 | JNJ
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is JOHNSON & JOHNSON's current cash & equivalents?
JOHNSON & JOHNSON (JNJ) annual cash & equivalents for 2025 was $19.71B, a 18.24% decline from 2024. JOHNSON & JOHNSON cash & equivalents for the quarter ending March 29, 2026 was $21.69B.
What was JOHNSON & JOHNSON's cash & equivalents in 2024?
JOHNSON & JOHNSON annual cash & equivalents for 2024 was $24.11B, a 70.63% increase from 2023.
What was JOHNSON & JOHNSON's cash & equivalents in 2023?
JOHNSON & JOHNSON annual cash & equivalents for 2023 was $14.13B, a 2.48% decline from 2022.
What is JOHNSON & JOHNSON's 4-year cash & equivalents CAGR?
JOHNSON & JOHNSON cash & equivalents grew at a compound annual growth rate (CAGR) of 8.96% from FY2021 to FY2025, going from $13.98B to $19.71B over 4 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $19.71B | -18.2% | 10-K |
| FY2024 | $24.11B | +70.6% | 10-K |
| FY2023 | $14.13B | -2.5% | 10-K |
| FY2022 | $14.49B | +3.6% | 10-K |
| FY2021 | $13.98B | -19.2% | 10-K |
| FY2019 | $17.30B | -4.4% | 10-K |
| FY2018 | $18.11B | +1.6% | 10-K |
| FY2017 | $17.82B | +29.8% | 10-K |
| FY2016 | $13.73B | -5.4% | 10-K |
| FY2014 | $14.52B | -30.6% | 10-K |
| FY2013 | $20.93B | +40.3% | 10-K |
| FY2012 | $14.91B | -23.0% | 10-K |
| FY2011 | $19.36B | +22.4% | 10-K |
| FY2010 | $15.81B | +46.8% | 10-K |
| FY2008 | $10.77B | +38.6% | 10-K |
| FY2007 | $7.77B | +90.3% | 10-K |
| FY2006 | $4.08B | - | 10-K |